Crinetics Pharmaceuticals, Inc.: cashflow_investing
| Value | {"amount": -48008000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-06-30 |
| Status | current |
| Entity | Crinetics Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:04:14.962457+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6816d7f6-9274-45ac-879d-924639d846cf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-25-175498Retrieved: 2026-08-19T17:04:14.962457+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001658247/cashflow-investing/2025-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6816d7f6-9274-45ac-879d-924639d846cf
History
- no predecessors — first report